Clinicopathological indicators for TERT promoter mutation in papillary thyroid carcinoma
Objective Mutations in the telomerase reverse transcriptase (TERT) promoter have been
reported as a convincing prognostic factor in papillary thyroid carcinomas (PTCs). We aimed …
reported as a convincing prognostic factor in papillary thyroid carcinomas (PTCs). We aimed …
PPARγ targets-derived diagnostic and prognostic index for papillary thyroid cancer
Simple Summary Through targeted next-generation sequencing of thyroid cancer-related
genes in monozygotic twins with papillary thyroid cancer (PTC), we identified common …
genes in monozygotic twins with papillary thyroid cancer (PTC), we identified common …
Correlation between BTG3, CASP9 and LRP4 single-nucleotide polymorphisms and susceptibility to papillary thyroid carcinoma
F Zhang, G Fan, X Wang - Biomarkers in Medicine, 2022 - Future Medicine
Objective: To study the association of BTG3, CASP9 and LRP4 single-nucleotide
polymorphisms with susceptibility to papillary thyroid carcinoma (PTC). Methods: The BTG3 …
polymorphisms with susceptibility to papillary thyroid carcinoma (PTC). Methods: The BTG3 …
Is multifocality a risk factor in low-risk papillary thyroid cancer?
G Sapuppo, S Grasso, G Di Benedetto… - Endokrynologia …, 2022 - journals.viamedica.pl
Introduction: Multifocality in papillary thyroid cancer (PTC) is a common event, ranging from
18% to 87%. Additional multiple foci are frequently very small and generally detected in …
18% to 87%. Additional multiple foci are frequently very small and generally detected in …